Full list of author information is available at the end of the articleIntroduction Nasopharyngeal carcinoma (NPC) is an epithelial malig-nancy with an annual incidence of 15 to 50 cases per 100,000 individuals in Southern China [1]. The progno-sis of patients with NPC in the early stages is generally favorable, although the incidence of relapse remains high for locoregionally advanced NPC [2,3]. Radiotherapy remains the primary mode of treatment for locoregional NPC. In the present study, we focused on evaluating the predictive value of the p53 pathway in outcomes of pa-tients with locoregional NPC in response to radiother-apy. The p53 gene is thought to be central in mediating response to commonly used cancer treatments, such as radiothera...
Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic...
Nasopharyngeal Carcinoma (NPC) is one of the common diseases in Asia countries especially in Souther...
p53 polymorphism at codon 72 is a known risk marker for various malignancies, but it has not been st...
Nasopharyngeal Carcinoma (NPC) appears to be the most prevalent cancer specifically in East and Sout...
[[abstract]]Objectives/ Hypothesis An important tumor suppressor gene, p53, plays a role in the regu...
Nasopharyngeal carcinoma (NPC) is a characteristic tumor displaying epidemiological, genetic and reg...
Background: The prevalence of NPC in Indonesia is 4.7 per 100,000 population each year. One of the f...
This study reports the incidence of p53 expression in 40 patients with recurrent nodal metastasis fr...
BACKGROUND AND PURPOSE:Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (NP...
Abstract Nasopharyngeal carcinoma (NPC) is a malignancy that is endemic to China and Southeast Asia....
Nasopharyngeal carcinoma (NPC) is the third most common cancer in the southern provinces of China, b...
Background and Purpose: Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (N...
Background. Nasopharyngeal carcinoma (NPC) is a rare but highly aggressive tumor that is predominant...
Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic...
<div><p>Background and Purpose</p><p>Treatment outcomes vary greatly in patients with nasopharyngeal...
Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic...
Nasopharyngeal Carcinoma (NPC) is one of the common diseases in Asia countries especially in Souther...
p53 polymorphism at codon 72 is a known risk marker for various malignancies, but it has not been st...
Nasopharyngeal Carcinoma (NPC) appears to be the most prevalent cancer specifically in East and Sout...
[[abstract]]Objectives/ Hypothesis An important tumor suppressor gene, p53, plays a role in the regu...
Nasopharyngeal carcinoma (NPC) is a characteristic tumor displaying epidemiological, genetic and reg...
Background: The prevalence of NPC in Indonesia is 4.7 per 100,000 population each year. One of the f...
This study reports the incidence of p53 expression in 40 patients with recurrent nodal metastasis fr...
BACKGROUND AND PURPOSE:Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (NP...
Abstract Nasopharyngeal carcinoma (NPC) is a malignancy that is endemic to China and Southeast Asia....
Nasopharyngeal carcinoma (NPC) is the third most common cancer in the southern provinces of China, b...
Background and Purpose: Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (N...
Background. Nasopharyngeal carcinoma (NPC) is a rare but highly aggressive tumor that is predominant...
Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic...
<div><p>Background and Purpose</p><p>Treatment outcomes vary greatly in patients with nasopharyngeal...
Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic...
Nasopharyngeal Carcinoma (NPC) is one of the common diseases in Asia countries especially in Souther...
p53 polymorphism at codon 72 is a known risk marker for various malignancies, but it has not been st...